{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T16:00:27Z","timestamp":1781798427225,"version":"3.54.5"},"reference-count":31,"publisher":"Elsevier BV","issue":"37","license":[{"start":{"date-parts":[[2013,8,1]],"date-time":"2013-08-01T00:00:00Z","timestamp":1375315200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2013,8]]},"DOI":"10.1016\/j.vaccine.2013.06.062","type":"journal-article","created":{"date-parts":[[2013,7,2]],"date-time":"2013-07-02T01:47:59Z","timestamp":1372729679000},"page":"3872-3878","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":67,"title":["Generation of a parvovirus B19 vaccine candidate"],"prefix":"10.1016","volume":"31","author":[{"given":"Sumana","family":"Chandramouli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelica","family":"Medina-Selby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Doris","family":"Coit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary","family":"Schaefer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Terika","family":"Spencer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis A.","family":"Brito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gillis","family":"Otten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian W.","family":"Mandl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter W.","family":"Mason","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip R.","family":"Dormitzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ethan C.","family":"Settembre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2013.06.062_bib0040","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1056\/NEJMra030840","article-title":"Parvovirus B19","volume":"350","author":"Young","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2013.06.062_bib0010","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1017\/S0022172400060964","article-title":"An outbreak of erythema infectiosum associated with human parvovirus infection","volume":"93","author":"Anderson","year":"1984","journal-title":"J Hyg (Lond)"},{"key":"10.1016\/j.vaccine.2013.06.062_bib0015","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1182\/blood-2003-01-0069","article-title":"Epidemiology of human parvovirus B19 in children with sickle cell disease","volume":"103","author":"Smith-Whitley","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.vaccine.2013.06.062_bib0020","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/S0140-6736(94)90011-6","article-title":"Congenital anaemia after transplacental B19 parvovirus infection","volume":"343","author":"Brown","year":"1994","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2013.06.062_bib0025","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1172\/JCI114274","article-title":"Immune response to B19 parvovirus and an antibody defect in persistent viral infection","volume":"84","author":"Kurtzman","year":"1989","journal-title":"J Clin Invest"},{"key":"10.1016\/j.vaccine.2013.06.062_bib0030","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1086\/505082","article-title":"Parvovirus B19 infection contributes to severe anemia in young children in Papua New Guinea","volume":"194","author":"Wildig","year":"2006","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2013.06.062_bib0035","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1186\/1471-2334-10-88","article-title":"Parvovirus B19 infection and severe anaemia in Kenyan children: a retrospective case control study","volume":"10","author":"Wildig","year":"2010","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.vaccine.2013.06.062_bib0045","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1002\/pd.940","article-title":"Fetal morbidity and mortality after acute human parvovirus B19 infection in pregnancy: prospective evaluation of 1018 cases","volume":"24","author":"Enders","year":"2004","journal-title":"Prenat Diagn"},{"key":"10.1016\/j.vaccine.2013.06.062_bib0050","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1001\/jama.281.12.1099","article-title":"Risk factors for parvovirus B19 infection in pregnancy","volume":"281","author":"Valeur-Jensen","year":"1999","journal-title":"JAMA"},{"key":"10.1016\/j.vaccine.2013.06.062_bib0005","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1097\/01.AOG.0000249611.67873.94","article-title":"Long-term outcome after fetal transfusion for hydrops associated with parvovirus B19 infection","volume":"109","author":"Nagel","year":"2007","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.vaccine.2013.06.062_bib0055","doi-asserted-by":"crossref","first-page":"6130","DOI":"10.1021\/cr200085w","article-title":"Phospholipase A2 enzymes: physical structure, biological function, disease implication, chemical inhibition, and therapeutic intervention","volume":"111","author":"Dennis","year":"2011","journal-title":"Chem Rev"},{"key":"10.1016\/j.vaccine.2013.06.062_bib0060","doi-asserted-by":"crossref","first-page":"3004","DOI":"10.1128\/JVI.67.6.3004-3009.1993","article-title":"Neutralizing linear epitopes of B19 parvovirus cluster in the VP1 unique and VP1\u2013VP2 junction regions","volume":"67","author":"Saikawa","year":"1993","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2013.06.062_bib0065","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1002\/(SICI)1097-0290(19960120)49:2<130::AID-BIT2>3.0.CO;2-R","article-title":"Production of parvovirus B19 vaccine in insect cells co-infected with double baculoviruses","volume":"49","author":"Tsao","year":"1996","journal-title":"Biotechnol Bioeng"},{"key":"10.1016\/j.vaccine.2013.06.062_bib0070","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1086\/368382","article-title":"Safety and immunogenicity of a recombinant parvovirus B19 vaccine formulated with MF59C.1","volume":"187","author":"Ballou","year":"2003","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2013.06.062_bib0075","first-page":"1","article-title":"Safety and immunogenicity of a candidate parvovirus B19 vaccine","author":"Bernstein","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2013.06.062_bib0080","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1093\/infdis\/167.5.1034","article-title":"Candidate recombinant vaccine for human B19 parvovirus","volume":"167","author":"Bansal","year":"1993","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2013.06.062_bib0085","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1086\/314648","article-title":"Quantitative analysis of neutralizing immune responses to human parvovirus B19 using a novel reverse transcriptase-polymerase chain reaction-based assay","volume":"179","author":"Bostic","year":"1999","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2013.06.062_bib0090","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1111\/j.1439-0450.2005.00871.x","article-title":"Parvovirus B19 VP2-proteins produced in Saccharomyces cerevisiae: comparison with VP2-particles produced by baculovirus-derived vectors","volume":"52","author":"Lowin","year":"2005","journal-title":"J Vet Med B Infect Dis Vet Public Health"},{"key":"10.1016\/j.vaccine.2013.06.062_bib0095","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/S1534-5807(01)00031-4","article-title":"A viral phospholipase A2 is required for parvovirus infectivity","volume":"1","author":"Z\u00e1dori","year":"2001","journal-title":"Dev Cell"},{"key":"10.1016\/j.vaccine.2013.06.062_bib0100","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1126\/science.6095448","article-title":"Characterization and molecular cloning of a human parvovirus genome","volume":"226","author":"Cotmore","year":"1984","journal-title":"Science"},{"key":"10.1016\/j.vaccine.2013.06.062_bib0105","doi-asserted-by":"crossref","first-page":"3917","DOI":"10.1128\/JCM.43.8.3917-3924.2005","article-title":"Design of novel conformational and genotype-specific antigens for improving sensitivity of immunoassays for hepatitis C virus-specific antibodies","volume":"43","author":"Lin","year":"2005","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.vaccine.2013.06.062_bib0110","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1093\/genetics\/121.2.223","article-title":"The MF alpha 1 gene of Saccharomyces cerevisiae: genetic mapping and mutational analysis of promoter elements","volume":"121","author":"Flessel","year":"1989","journal-title":"Genetics"},{"key":"10.1016\/j.vaccine.2013.06.062_bib0115","doi-asserted-by":"crossref","first-page":"2253","DOI":"10.1099\/vir.0.81849-0","article-title":"Hepatitis C virus polyprotein vaccine formulations capable of inducing broad antibody and cellular immune responses","volume":"87","author":"Vajdy","year":"2006","journal-title":"J Gen Virol"},{"key":"10.1016\/j.vaccine.2013.06.062_bib0120","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.jcv.2005.12.008","article-title":"Development of an improved method of detection of infectious parvovirus B19","volume":"35","author":"Wong","year":"2006","journal-title":"J Clin Virol"},{"key":"10.1016\/j.vaccine.2013.06.062_bib0125","doi-asserted-by":"crossref","first-page":"e9496","DOI":"10.1371\/journal.pone.0009496","article-title":"Erythroid progenitor cells expanded from peripheral blood without mobilization or preselection: molecular characteristics and functional competence","volume":"5","author":"Filippone","year":"2010","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2013.06.062_bib0130","doi-asserted-by":"crossref","first-page":"2470","DOI":"10.1128\/JVI.02247-07","article-title":"Ex vivo-generated CD36+ erythroid progenitors are highly permissive to human parvovirus B19 replication","volume":"82","author":"Wong","year":"2008","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2013.06.062_bib0135","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0163-4453(86)92563-6","article-title":"Production and immunological analysis of recombinant hepatitis B vaccine","volume":"13","author":"Emini","year":"1986","journal-title":"J Infect"},{"key":"10.1016\/j.vaccine.2013.06.062_bib0140","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1002\/jps.20696","article-title":"Disassembly and reassembly of yeast-derived recombinant human papillomavirus virus-like particles (HPV VLPs)","volume":"95","author":"Mach","year":"2006","journal-title":"J Pharm Sci"},{"key":"10.1016\/j.vaccine.2013.06.062_bib0145","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1172\/JCI115812","article-title":"Unique region of the minor capsid protein of human parvovirus B19 is exposed on the virion surface","volume":"89","author":"Rosenfeld","year":"1992","journal-title":"J Clin Invest"},{"key":"10.1016\/j.vaccine.2013.06.062_bib0150","doi-asserted-by":"crossref","first-page":"7306","DOI":"10.1128\/JVI.00512-08","article-title":"Visualization of the externalized VP2 N termini of infectious human parvovirus B19","volume":"82","author":"Kaufmann","year":"2008","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2013.06.062_bib0155","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1056\/NEJM198908243210807","article-title":"Pure red-cell aplasia of 10 years\u2019 duration due to persistent parvovirus B19 infection and its cure with immunoglobulin therapy","volume":"321","author":"Kurtzman","year":"1989","journal-title":"N Engl J Med"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X13008542?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X13008542?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,2,26]],"date-time":"2022-02-26T19:30:50Z","timestamp":1645903850000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X13008542"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,8]]},"references-count":31,"journal-issue":{"issue":"37","published-print":{"date-parts":[[2013,8]]}},"alternative-id":["S0264410X13008542"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2013.06.062","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2013,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Generation of a parvovirus B19 vaccine candidate","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2013.06.062","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}